Variables | Categories | Frequency | Survival status of SAM cases | CHR | AHR | P value | |
---|---|---|---|---|---|---|---|
Attrition (71) | Censored | ||||||
Age |  ≥ 24 months | 458 (60.26) | 42 (5.52) | 416 (54.7) | 1 | 1 |  |
25–48 months | 219 (28.82) | 22 (2.89) | 197 (25.9) | 1.2 (.68;2.2) | 1.19 (0.6;2.2) | 0.27 | |
48–60 months | 83 (10.92) | 7 (0.92) | 76 (10.1) | 2.11 (.86;1.9) | 1.8 (0.7:1.5) | 0.11 | |
Sex | Male | 330 (43.82) | 47 (6.18) | 283 (37.2) | 2.3 (1.3:4.1) | 1.56 (.85;2.78) | 0.14 |
Female | 430 (56.18) | 24 (3.15) | 406 (53.4) | 1 | 1 | Â | |
Resident | Rural | 570 (74.16) | 6 (0.78) | 184 (24.2) | 6.3 (1.5;26.1) | 6.3 (1.6;26.4) | 0.012* |
Urban | 190 (27.84) | 65 (8.55) | 505 (66.4) | 1 | 1 | Â | |
Anemia |  ≥ 10 mg/dl | 511 (66.24) | 20 (2.6) | 482 (63.4) | 1 | 1 |  |
 < 10 mg/dl | 258 (33.76) | 51 (6.7) | 207 (27.2) | 5.1 (2.8;9.3) | 1.7 (0.9:2.1) | 0.16 | |
Diarrheas | Yes | 409 (53.82) | 33 (4.4) | 376 (49.4) | 1.7 (0.77;2.9) | 1.2 (0.8;2.4) | 0.22 |
No | 351 (46.18) | 38 (5.0) | 313 (41.1) | 1 | 1 | Â | |
Vitamin A | Given | 584 (76.84) | 56 (7.36) | 528 (69.4) | 1.3 (.67;2.5) | 1.5 (.7;2.6) | 0.12 |
Not given | 176 (23.16) | 15 (1.9) | 161 (21.1) | 1 | 1 | Â | |
Folic acids | Given | 525 (69.08) | 50 (6.57) | 475 (62.5) | 1.3 (0.7;2.3) | 1.3 (0.6;2.4) | 0.34 |
Not given | 235 (30.92) | 21 (2.7) | 214 (28.15) | 1 | Â | Â | |
Pneumonia | Yes | 452 (59.47) | 61 (8.1) | 397 (52.2) | 2.9 (2.4;10.3) | 1.2 (0.8;3.2) | 0.08 |
No | 308 (40.53) | 10 (1.3) | 292 (38.4) | 1 | 1 | Â | |
TB | Present | 45 (5.92) | 6 (0.78) | 39 (5.13) | 1.1 (0.26;4.5) | 1.1 (0.3;1.2) | 0.3 |
Absent | 715 (94.08) | 65 (8.5) | 650 (85.5) | 1 | 1 | Â | |
Family size |  ≤ 4 | 487 (64.97) | 25 (3.2) | 462 (60.78) | 1 | 1 |  |
 > 5 | 273 (35.1%) | 46 (6.1) | 227 (29.8) | 3.1 (1.7;5.4) | 0.9 (.7;1.4) | 0.12 | |
Deworming | Yes | 331 (43.55) | 36 (4.7) | 295 (38.8) | 1 | Â | Â |
No | 429 (56.45) | 35 (4.6) | 394 (51.8) | 1.2 (0.68;2.0) | 1.1 (0.7;2) | 0.11 | |
Amoxicillin | Given | 624 (82.11) | 62 (8.2) | 662 (87.1) | 1 | 1 | Â |
Not given | 136 (17.89) | 9 (1.1) | 127 (16.7) | 0.9 (.43;1.95) | 0.9 (.43;1.9) | 0.11 | |
Vaccine status | Completed | 572 (75.26) | 54 (7.1) | 518 (68.1) | 1 | 1 | Â |
Not completed | 188 (24.74) | 17 (2.2) | 171 (22.5) | 1.3 (.69;2.64) | 1.1 (.5;2.2) | 0.41 | |
HIV infection | Positive | 42 (5.53) | 5 (0.6) | 37 (4.86) | 1.1 (.45;2.9) | 1.1 (.3;2.1) | 0.22 |
Negative | 718 (94.47) | 66 (8.6) | 652 (85.78) | 1 | 1 | Â | |
Skin infection | Yes | 290 (38.16) | 36 (4.7) | 254 (33.4) | 1.4 (.80;2.4) | 1.2 (.6;2.1) | 0.15 |
No | 470 (61.84) | 35 (4.6) | 435 (57.2) | 1 | 1 | Â | |
Zink supplement | Yes | 349 (45.9) | 33 (4.3) | 373 (49.1) | 1 | 1 | Â |
No | 411 (54.08) | 38 (5.0) | 316 (41.5) | 1.2 (.64;1.9) | 0.8 (.6;1.9) | 0.31 | |
Maternal education | Formally educated | 516 (67.89) | 16 (2.2) | 500 (65.7) | 1 | 1 | Â |
Had No formal education | 244 (32.2) | 55 (7.2) | 189 (24.8) | 9.6 (4.8;19.2) | 5.3 (2.6:10.9) | 0.01* | |
Admission types | New | 685 (90.13) | 42 (5.5) | 643 (84.6) | 1 | 1 | Â |
Re-admission | 75 (9.8) | 29 (3.8) | 46 (6.1) | 4.9 (2.7;8.4) | 2.8 (1.5;5.3) | 0.01* |